Decrease of fructosamine levels during treatment with adalimumab in patients with both diabetes and rheumatoid arthritis.
- Published in:
- European Journal of Endocrinology, 2007, v. 156, n. 3, p. 291, doi. 10.1530/EJE-06-0693
- By:
- Publication type:
- Article